Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Praxis Precision Medicines, Inc. | exhibit312pfo302certificat.htm |
| EX-31.1 - EX-31.1 - Praxis Precision Medicines, Inc. | exhibit311peo302certificat.htm |
| EX-23.1 - EX-23.1 - Praxis Precision Medicines, Inc. | exhibit231eyconsent.htm |
| EX-10.3 - EX-10.3 - Praxis Precision Medicines, Inc. | exhibit1032017plan.htm |
| EX-4.3 - EX-4.3 - Praxis Precision Medicines, Inc. | exhibit43descriptionofsecu.htm |
| 10-K - 10-K - Praxis Precision Medicines, Inc. | prax-20201231.htm |
Exhibit 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND INTERIM PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Praxis Precision Medicines, Inc. (the “Company”) for the fiscal year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |||||||
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. | |||||||
| Date: March 17, 2021 | By: | /s/ MARCIO SOUZA | ||||||||||||||||||
| Marcio Souza | ||||||||||||||||||||
| Chief Executive Officer | ||||||||||||||||||||
| (Principal Executive Officer) | ||||||||||||||||||||
| Date: March 17, 2021 | By: | /s/ LAUREN MASTROCOLA | ||||||||||||||||||
| Lauren Mastrocola | ||||||||||||||||||||
| Principal Accounting Officer and Interim Principal Financial Officer | ||||||||||||||||||||